Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

cyclopia sequence 6Prostatic Neoplasms 6Neoplasm Metastasis 6Breast Neoplasms 6Lung Neoplasms 4Dyspnea 4Recurrence 3Primary Myelofibrosis 3Oropharyngeal Neoplasms 3Multiple Myeloma 3Esophageal Neoplasms 3Carcinoma, Squamous Cell 3Squamous Cell Carcinoma of Head and Neck 2Polycythemia Vera 2Pain 2Kidney Neoplasms 2Head and Neck Neoplasms 2Glioblastoma 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Thrombocythemia, Essential 1Splenomegaly 1Speech 1Sezary Syndrome 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Plexosarcoma 1Pathologic Complete Response 1

Interventions

Therapeutics 1Testosterone 1Surveys and Questionnaires 1Letrozole 1Hyaluronic Acid 1Glucosamine 1Glucaric Acid 1Chondroitin Sulfates 1Chondroitin 1Cholecalciferol 1Cannabidiol 1Calcium Gluconate 1Calcium Citrate 1Calcium Carbonate 1Calcium 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Arthralgia × Surveys and Questionnaires × Clear all
NCT06728579 2026-04-17

Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
200 enrolled

Cancer Pain, Pain, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡